Ronapreve: 'Most vulnerable' to get new Covid drug

Ronapreve: 'Most vulnerable' to get new Covid drug The UK's "most vulnerable" hospital patients, who are unable to build up an antibody response to Covid, will be offered new drug Ronapreve from Monday.

The new Covid treatment, approved just last month, uses a pair of laboratory-made antibodies to attack the virus. BBC News

See also:

• First Covid booster jabs given to NHS staff BBC News
• Covid calculator spots people vulnerable despite jabs BBC News
• Sajid Javid: 'We need to avoid unsustainable pressure on the NHS' BBC News
• Covid: Vaccine volunteers sought for children's second dose study BBC News
• Long Covid less common than feared - ONS study BBC News
• People with Down's syndrome are most at risk of death after having two Covid vaccines, study finds The Daily Mail
• Covid Delta variant 'will hunt down anyone who's not had jab', scientific advisers warn No 10 The Daily Mail
• NHS aims to deliver over 1m daily Covid and flu jabs in race against time The Guardian
• No 10 accused of sidelining behaviour experts on latest Covid measures The Guardian